Revolution Medicines officer proposes $112K share sale

Two of the three earlier common-stock sales are identified as 10b5-1 sales.

Rhea-AI Filing Summary

Revolution Medicines, Inc. (RVMD) officer Anthony Mancini reported a proposed sale of 587 common shares, with an aggregate market value of $111,964.38, through Morgan Stanley Smith Barney LLC on September 24, 2026. Mancini also reported three common-stock sales during the preceding three months: 1,764 shares on September 18, 2026; 1,774 shares on September 15, 2026; and 15,448 shares on September 10, 2026. The September 18 and September 10 sales are identified as 10b5-1 sales.

Key Figures

Proposed shares: 587 shares Proposed sale aggregate market value: $111,964.38 Shares sold: 1,764 shares +5 more

8 metrics

Proposed shares 587 shares Proposed sale by Anthony Mancini on September 24, 2026

Proposed sale aggregate market value $111,964.38 Proposed sale by Anthony Mancini

Shares sold 1,764 shares September 18, 2026

Aggregate market value of sale $347,402.16 Sale on September 18, 2026

Shares sold 1,774 shares September 15, 2026

Aggregate market value of sale $353,449.03 Sale on September 15, 2026

Shares sold 15,448 shares September 10, 2026

Aggregate market value of sale $3,153,807.11 Sale on September 10, 2026

Key Terms

Restricted Stock Units, 10b5-1 Sales, Rule 144

3 terms

Restricted Stock Units financial

"Restricted Stock Units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 Sales regulatory

"10b5-1 Sales for ANTHONY MANCINI"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RVMD shares is officer Anthony Mancini proposing to sell?

Anthony Mancini reported a proposed sale of 587 common shares on September 24, 2026, with an aggregate market value of $111,964.38.

What prior RVMD stock sales did Anthony Mancini report?

Mancini reported sales of 1,764 shares on September 18, 2026, 1,774 shares on September 15, 2026, and 15,448 shares on September 10, 2026. Their respective aggregate values were $347,402.16, $353,449.03, and $3,153,807.11.

Which of Anthony Mancini's prior RVMD sales are identified as 10b5-1 sales?

The sales identified as 10b5-1 sales were 1,764 shares on September 18, 2026 and 15,448 shares on September 10, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/24/2026 - 04:42 PM EDT Accepted by SEC EDGAR 09/24/2026 - 04:42 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002124509
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Revolution Medicines, Inc.
SEC File Number	001-39219
Address of Issuer	700 Saginaw Drive Redwood City CALIFORNIA 94063
Phone	6504816801
Name of Person for Whose Account the Securities are To Be Sold	ANTHONY MANCINI
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	587	111964.38	214336418	09/24/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/15/2026	Restricted Stock Units	Issuer			587	09/15/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ANTHONY MANCINI 700 Saginaw Drive Redwood City CA 94063	Common	09/18/2026	1764	347402.16
ANTHONY MANCINI 700 Saginaw Drive Redwood City CA 94063	Common	09/15/2026	1774	353449.03
10b5-1 Sales for ANTHONY MANCINI 700 Saginaw Drive Redwood City CA 94063	Common	09/10/2026	15448	3153807.11

144: Remarks and Signature

Remarks
Date of Notice	09/24/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Anthony Mancini
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)